As of 2025-09-18, the EV/EBITDA ratio of Cellectis SA (ALCLS.PA) is -4.54. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ALCLS.PA's latest enterprise value is 225.50 mil EUR. ALCLS.PA's TTM EBITDA according to its financial statements is -49.67 mil EUR. Dividing these 2 quantities gives us the above ALCLS.PA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 2.7x - 5.7x | 3.2x |
| Forward P/E multiples | 6.4x - 9.8x | 8.0x |
| Fair Price | (4.17) - (3.78) | (3.71) |
| Upside | -254.1% - -239.8% | -237.2% |
| Date | EV/EBITDA |
| 2025-09-16 | -4.65 |
| 2025-09-15 | -4.60 |
| 2025-09-12 | -4.62 |
| 2025-09-11 | -4.77 |
| 2025-09-10 | -4.48 |
| 2025-09-09 | -4.32 |
| 2025-09-08 | -4.23 |
| 2025-09-05 | -4.04 |
| 2025-09-04 | -3.99 |
| 2025-09-03 | -3.96 |
| 2025-09-02 | -3.93 |
| 2025-09-01 | -4.20 |
| 2025-08-29 | -4.04 |
| 2025-08-28 | -4.06 |
| 2025-08-27 | -4.08 |
| 2025-08-26 | -4.03 |
| 2025-08-25 | -4.19 |
| 2025-08-22 | -4.36 |
| 2025-08-21 | -4.24 |
| 2025-08-20 | -4.43 |
| 2025-08-19 | -4.56 |
| 2025-08-18 | -4.39 |
| 2025-08-15 | -4.41 |
| 2025-08-14 | -4.41 |
| 2025-08-13 | -4.31 |
| 2025-08-12 | -4.06 |
| 2025-08-11 | -4.05 |
| 2025-08-08 | -4.16 |
| 2025-08-07 | -4.25 |
| 2025-08-06 | -4.07 |
| 2025-08-05 | -4.10 |
| 2025-08-04 | -4.70 |
| 2025-08-01 | -4.33 |
| 2025-07-31 | -4.07 |
| 2025-07-30 | -4.38 |
| 2025-07-29 | -4.25 |
| 2025-07-28 | -4.53 |
| 2025-07-25 | -3.96 |
| 2025-07-24 | -3.48 |
| 2025-07-23 | -3.57 |
| 2025-07-22 | -2.94 |
| 2025-07-21 | -2.93 |
| 2025-07-18 | -3.00 |
| 2025-07-17 | -3.02 |
| 2025-07-16 | -3.09 |
| 2025-07-15 | -3.30 |
| 2025-07-14 | -3.13 |
| 2025-07-11 | -2.69 |
| 2025-07-10 | -2.65 |
| 2025-07-09 | -2.67 |